anti-infectives Archives -

Shares in PolyPid have been under pressure after the Israeli biotech reported its antibiotic for surgical site infections

Data dive could give PolyPid antibiotic a lifeline

https://pharmaphorum.com/news/data-dive-could-give-polypid-antibiotic-a-lifeline/

A new company set up to use machine learning to find new anti-infective drugs – ArrePath – has

Boehringer backs AI-powered anti-infective startup ArrePath

https://pharmaphorum.com/news/boehringer-backs-ai-powered-anti-infective-startup-arrepath/

Roche’s new influenza drug Xofluza can dramatically prevent the spread of the virus when used as a preventive

Roche’s Xofluza limits spread of flu virus, says new study

https://pharmaphorum.com/news/roches-xofluza-limits-spread-of-flu-virus-says-new-study/

Gilead Sciences’ Descovy, its successor to HIV pre-exposure prophylaxis (PrEP) therapy Truvada, is heading into an FDA advisory

FDA reviewer backs Gilead’s Descovy for PrEP, but not in women

https://pharmaphorum.com/news/fda-reviewer-backs-gileads-descovy-for-prep-but-not-in-women/

ViiV Healthcare has submitted its once-monthly two-drug injectable therapy for HIV to the EMA, setting up possible approval

ViiV files monthly HIV jab in Europe

https://pharmaphorum.com/news/viiv-files-monthly-hiv-jab-in-europe/

ViiV Healthcare has new data on its first-in-class HIV drug fostemsavir that back up its long-term effects, and

ViiV’s first-in-class HIV drug on course for filings this year

https://pharmaphorum.com/news/viivs-first-in-class-hiv-drug-on-course-for-filings-this-year/

An exclusive interview with Dr. Antonio DiGiandomenico, Principal Scientist, MedImmune has been released SMi Reports: An exclusive interview

SMi’s Exclusive Interview with MedImmune Principal Scientist just released

https://pharmaphorum.com/partner-content/smis-exclusive-interview-with-medimmune-principal-scientist-just-released/

anti-infectives